EP1032266A4 - Use of delta5-androstene-3beta-ol-7,17-dione in the treatment of arthritis - Google Patents

Use of delta5-androstene-3beta-ol-7,17-dione in the treatment of arthritis

Info

Publication number
EP1032266A4
EP1032266A4 EP98958020A EP98958020A EP1032266A4 EP 1032266 A4 EP1032266 A4 EP 1032266A4 EP 98958020 A EP98958020 A EP 98958020A EP 98958020 A EP98958020 A EP 98958020A EP 1032266 A4 EP1032266 A4 EP 1032266A4
Authority
EP
European Patent Office
Prior art keywords
delta5
3beta
androstene
dione
arthritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98958020A
Other languages
German (de)
French (fr)
Other versions
EP1032266A1 (en
Inventor
Charles E Weeks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Humanetics Corp
Original Assignee
Humanetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Humanetics Corp filed Critical Humanetics Corp
Publication of EP1032266A1 publication Critical patent/EP1032266A1/en
Publication of EP1032266A4 publication Critical patent/EP1032266A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
EP98958020A 1997-11-19 1998-11-17 Use of delta5-androstene-3beta-ol-7,17-dione in the treatment of arthritis Withdrawn EP1032266A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6619797P 1997-11-19 1997-11-19
US66197P 1997-11-19
PCT/US1998/024458 WO1999025192A1 (en) 1997-11-19 1998-11-17 USE OF Δ5-ANDROSTENE-3β-OL-7,17-DIONE IN THE TREATMENT OF ARTHRITIS

Publications (2)

Publication Number Publication Date
EP1032266A1 EP1032266A1 (en) 2000-09-06
EP1032266A4 true EP1032266A4 (en) 2003-07-16

Family

ID=22067899

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98958020A Withdrawn EP1032266A4 (en) 1997-11-19 1998-11-17 Use of delta5-androstene-3beta-ol-7,17-dione in the treatment of arthritis

Country Status (4)

Country Link
EP (1) EP1032266A4 (en)
AU (1) AU766908B2 (en)
CA (1) CA2311471A1 (en)
WO (1) WO1999025192A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002225881A1 (en) * 2000-11-30 2002-06-11 Humanetics Corporation Treatment of chronic fatigue syndrome and fibromyalgia syndrome
US6399084B1 (en) 2001-03-05 2002-06-04 Humanetics Corporation Method for diminishing wrinkles and fine lines of the skin by the topical application of Δ5-androstene-3β-ol-7, 17 dione and metabolizable precursors thereof
US6399085B1 (en) 2001-03-05 2002-06-04 Humanetics Corporation Method of moisturizing the skin by the topical application of Δ5-androstene-3β-ol-7,17 dione and metabolizable precursors thereof
US6465446B1 (en) 2001-03-12 2002-10-15 John C. Dykstra Treatment of dermatitis by the topical application of Δ5-androstene-3β-ol-7,17 dione and metabolizable precursors thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3107256A (en) * 1961-09-20 1963-10-15 Chemetron Corp 16-trifluoroacetyl derivatives of 5-androsten-3beta-ol-17-one
US4628052A (en) * 1985-05-28 1986-12-09 Peat Raymond F Pharmaceutical compositions containing dehydroepiandrosterone and other anesthetic steroids in the treatment of arthritis and other joint disabilities
US4812447A (en) * 1985-10-22 1989-03-14 City Of Hope Method for the treatment of nervous system degeneration
US5292730A (en) * 1990-08-29 1994-03-08 Humanetics Corporation Modulation of immune system with Δ5-androstenes
JPH09151197A (en) * 1995-11-29 1997-06-10 L T T Kenkyusho:Kk Therapeutic agent for autoimmune disease

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3107256A (en) * 1961-09-20 1963-10-15 Chemetron Corp 16-trifluoroacetyl derivatives of 5-androsten-3beta-ol-17-one
US4628052A (en) * 1985-05-28 1986-12-09 Peat Raymond F Pharmaceutical compositions containing dehydroepiandrosterone and other anesthetic steroids in the treatment of arthritis and other joint disabilities
US4812447A (en) * 1985-10-22 1989-03-14 City Of Hope Method for the treatment of nervous system degeneration
US5292730A (en) * 1990-08-29 1994-03-08 Humanetics Corporation Modulation of immune system with Δ5-androstenes
JPH09151197A (en) * 1995-11-29 1997-06-10 L T T Kenkyusho:Kk Therapeutic agent for autoimmune disease

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 1997, no. 10 31 October 1997 (1997-10-31) *
See also references of WO9925192A1 *

Also Published As

Publication number Publication date
CA2311471A1 (en) 1999-05-27
AU766908B2 (en) 2003-10-23
EP1032266A1 (en) 2000-09-06
WO1999025192A1 (en) 1999-05-27
AU1414299A (en) 1999-06-07

Similar Documents

Publication Publication Date Title
EP1032377A4 (en) Substituted 2-aminoacetamides and the use thereof
ZA987839B (en) Combination therapy.
HUP9900163A2 (en) Process for the preparation of sterol-and stanol-esters, and use thereof
ZA987843B (en) Combination therapy.
HUP0001603A3 (en) Cycloalkylalkanecarboxamides and the production and use thereof
AU2418499A (en) Org-5222 in the treatment of depression
ZA978640B (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis.
PL347542A1 (en) Therapeutic product and its use
GB9714971D0 (en) Assays,therapeutic methods and means
GB9815312D0 (en) Biomas treatment
GB9705200D0 (en) Well treatment with particles
ZA973843B (en) Treatment of asthma with TNFR-lg.
EP1032266A4 (en) Use of delta5-androstene-3beta-ol-7,17-dione in the treatment of arthritis
GB2355006B (en) Materials treatment
GB9811525D0 (en) Sewage treatment
AU3061199A (en) Skin treatment compositions and the use thereof
GB9609944D0 (en) An improvement in the treatment of wastes
GB9815497D0 (en) Treatment
GB9818524D0 (en) Inorgasmia treatment
GB9707104D0 (en) An improvement in the treatment of bio-waste
AU6409598A (en) An improvement in the treatment of wastes
ZA991021B (en) Benzofuran-4-carboxamides and their therapeutic use.
GB9828550D0 (en) Treatment
ZA9711116B (en) The treatment of materials.
SI1011649T1 (en) Use of endipalene in the treatment of psoriasis

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000526

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20030603

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060601